학술논문
Oncolytic effect of SARS‐CoV‐2 in a patient with mycosis fungoides: A case report
Document Type
article
Source
Clinical Case Reports, Vol 10, Iss 4, Pp n/a-n/a (2022)
Subject
Language
English
ISSN
2050-0904
Abstract
Abstract The most common variant of cutaneous T‐cell lymphomas (CTCL) is mycosis fungoides (MF). Patients with MF often experience a chronic course of disease. The spontaneous regression (SR) of MF is rare, and the factors that predict SR have not been recognized yet. Here, we are reporting a case of persistent MF who had prominent remission after COVID‐19. This case report supports the possible antineoplastic effect of SARS‐CoV‐2. Understanding the underlying etiology of such effect can result in development of new target therapies for MF.